NCT02298959 2026-03-19Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced CancerNational Cancer Institute (NCI)Phase 1 Active not recruiting59 enrolled
NCT06626256 2025-12-24STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaCity of Hope Medical CenterPhase 1 Withdrawn
NCT00900302 2016-02-10OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerOHSU Knight Cancer InstituteCompleted98 enrolled